Skip to main content

A Hapten Generated from an Oxidation Fragment of Docosahexaenoic Acid Is Sufficient to Initiate Age-Related Macular Degeneration

Abstract

The protein adduct carboxyethylpyrrole (CEP) is present in age-related macular degeneration (AMD) eye tissue and in the blood of AMD patients at higher levels than found in age-matched non-AMD tissues. Autoantibodies to CEP are also higher in AMD blood samples than in controls. To test the hypothesis that this hapten is causally involved in initiating an inflammatory response in AMD, we immunized C57BL/6J mice with mouse serum albumin (MSA) adducted with CEP. Immunized mice develop antibodies to CEP, fix complement component-3 in Bruch’s membrane, accumulate drusen below the retinal pigment epithelium during aging, show decreased a- and b-wave amplitudes in response to light, and develop lesions in the retinal pigment epithelium mimicking geographic atrophy, the blinding end-stage condition characteristic of the dry form of AMD. Inflammatory cells are present in the region of lesions and may be actively involved in the pathology observed. We conclude that early immunization of mice with CEP-adducted MSA sensitizes these animals to the ongoing production of CEP adducts in the outer retina where DHA is abundant and the conditions for oxidative damage are permissive. In response to this early sensitization, the immune system mounts a complement-mediated attack on the cells of the outer retina where CEP adducts are formed. This animal model for AMD is the first that was developed from an inflammatory signal discovered in eye tissue and blood from AMD patients. It provides a novel opportunity for dissecting the early pathology of AMD and the immune response contributing to this disorder. The availability of a mouse with a mechanistically based AMD-like disease that progresses rapidly is highly desirable. Such a model will allow for the efficient preclinical testing of the much-needed therapeutics quickly and inexpensively.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Javitt JC, Zhou Z, Maguire MG, Fine SL, Willke RJ (2003) Ophthalmol 110:1534–1539

    Article  Google Scholar 

  2. Augood C, Vingerling JR, de Jong PT, Chakravarthy U, Seland J, Soubrane G, Tomazzoli L, Topouzis F, Bentham G, Rahu M, Vioque J, Young IS, Fletcher AE (2006) Arch Ophthalmol 124:529–535

    Article  PubMed  Google Scholar 

  3. Curcio C, Millican C, Bailey T, Kruth H (2001) Invest Ophthalmol Vis Sci 42:265–274

    CAS  PubMed  Google Scholar 

  4. Hussain A, Rowe L, Marshall J (2002) J Opt Soc Am A Opt Image Sci Vis 19:166–172

    Article  CAS  PubMed  Google Scholar 

  5. Moore D, Hussain A, Marshall J (1995) Invest Ophthalmol Vis Sci 36:1290–1297

    CAS  PubMed  Google Scholar 

  6. Bressler SB, Maguire MG, Bressler NM, Fine SL (1990) Arch Ophthalmol 108:1442–1447

    CAS  PubMed  Google Scholar 

  7. Sarks SH, van Driel D, Maxwell L, Killingsworth M (1980) Trans Ophthalmol Soc UK 100:414–422

    CAS  PubMed  Google Scholar 

  8. Vinding T (1990) Acta Ophthalmol 68:410–414

    Article  CAS  Google Scholar 

  9. Holz FG, Bellman C, Staudt S, Schutt F, Volcker HE (2001) Invest Ophthalmol Vis Sci 42:1051–1056

    CAS  PubMed  Google Scholar 

  10. Hollyfield JG, Crabb JW, Salomon RG (2003) Adv Exp Med Biol 533:83–89

    CAS  PubMed  Google Scholar 

  11. Crabb JW, Miyagi M, Gu X, Shadrach KG, West KA, Sakaguchi H, Kamei M, Hasan A, Yan L, Rayborn ME, Salomon RG, Hollyfield JG (2002) Proc Natl Acad Sci USA 99:14682–14687

    Article  CAS  PubMed  Google Scholar 

  12. Sakaguchi H, Miyagi M, Shadrach KG, Rayborn ME, Crabb JW, Hollyfield JG (2002) Exp Eye Res 74:547–549

    Article  CAS  PubMed  Google Scholar 

  13. Bando H, Shadrach KG, Rayborn ME, Crabb JW, Hollyfield JG (2007) Exp Eye Res 84:135–142

    Article  CAS  PubMed  Google Scholar 

  14. Rayborn ME, Sakaguchi H, Shadrach KG, Crabb JS, Crabb JW, Hollyfield JG (2006) Adv Exp Med Biol 572:75–78

    Article  CAS  PubMed  Google Scholar 

  15. Nakata K, Crabb JW, Hollyfield JG (2005) Exp Eye Res 80:821–826

    Article  CAS  PubMed  Google Scholar 

  16. Johnson LV, Leitner WP, Staples MK, Anderson DH (2001) Exp Eye Res 73:887–896

    Article  CAS  PubMed  Google Scholar 

  17. Hageman GS, Mullins RF (1999) Mol Vis 5:28–37

    CAS  PubMed  Google Scholar 

  18. Anderson DH, Mullins RF, Hageman GS, Johnson LV (2002) Am J Ophthalmol 134:411–431

    Article  CAS  PubMed  Google Scholar 

  19. Hageman GS, Luthert PJ, Chong NH, Johnson LV, Anderson DH, Mullins RF (2001) Prog Retina Eye Res 20:705–732

    Article  CAS  Google Scholar 

  20. Johnson LV, Ozaki S, Staples ML, Erickson PA, Anderson DH (2000) Exp Eye Res 70:441–449

    Article  CAS  PubMed  Google Scholar 

  21. Doyne RW (1989) Trans Ophthalmol Soc U K 19:71–71

    Google Scholar 

  22. Gass JDM (1987) Stereoscopic atlas of macular diseases. CV Mosby, St. Louis

    Google Scholar 

  23. Meyers SM, Zachary AA (1988) Arch Ophthalmol 106:651–653

    CAS  PubMed  Google Scholar 

  24. Seddon JM, Ajani UA, Mitchell BD (1997) Am J Ophthalmol 123:199–206

    CAS  PubMed  Google Scholar 

  25. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, Henning AK, SanGiovanni JP, Mane SM, Mayne ST, Bracken MB, Ferris F, Ott J, Barnstable C, Hoh J (2005) Science 308:385–389

    Article  CAS  PubMed  Google Scholar 

  26. Edwards AO, Ritter R, Abel KJ, Manning A, Panhuysen C, Farrer LA (2005) Science 308:421–424

    Article  CAS  PubMed  Google Scholar 

  27. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, Hageman JL, Stockman HA, Borchardt JD, Gehrs KM, Smith RJ, Silvestri G, Russell SR, Klaver CC, Barbazetto I, Chang G, Yannuzzi LA, Barile GR, Merriam JC, Smith RT, Olsh AK, Bergeron J, Zernant J, Merriam JE, Gold B, Dean M, Allikmets R (2005) Proc Natl Acad Sci U S A 102:7227–7232

    Article  CAS  PubMed  Google Scholar 

  28. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P, Spencer KL, Kwan SY, Noureddine M, Gilbert JR, Schnetz-Boutaud N, Agarwal A, Postel EA, Pericak-Vance MA (2005) Science 308:419–421

    Article  CAS  PubMed  Google Scholar 

  29. Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, Gehrs KM, Cramer K, Neel J, Bergeron J, Barile GR, Smith RT, Group AGCS, Hageman GS, Dean M, Allikmets R (2006) Nature Genet 38:458–462

    Article  CAS  PubMed  Google Scholar 

  30. Gu X, Meer SG, Miyagi M, Rayborn ME, Hollyfield JG, Crabb JW, Salomon RG (2003) J Biol Chem 278:42027–42035

    Article  CAS  PubMed  Google Scholar 

  31. Seddon JM, Willett WC, Speizer FE, Hankinson SE (1996) J Am Med Assoc 276:1141–1146

    Article  CAS  Google Scholar 

  32. Klein RJ, Klein BE, Cruickshanks KJ (1999) Prog Retin Eye Res 18:371–389

    Article  CAS  PubMed  Google Scholar 

  33. Snow K, Seddon JM (1999) Ophthalmic Epidemiol 6:125–143

    Article  CAS  PubMed  Google Scholar 

  34. Christen WG, Glynn RJ, Manson JE, Ajani UA, Buring JE (1996) JAMA 276:1147–1151

    Article  CAS  PubMed  Google Scholar 

  35. Smith W, Mitchell P, Leeder SR (1996) Arch Ophthalmol 114:1518–1523

    CAS  PubMed  Google Scholar 

  36. Solberg Y, Rosner M, Belkin M (1998) Surv Ophthalmol 42:535–547

    Article  CAS  PubMed  Google Scholar 

  37. AREDS RG (2001) Arch Ophthalmol 119:1439–1452

    Google Scholar 

  38. Fliesler SJ, Anderson RE (1983) Prog Lipid Res 22:79–131

    Article  CAS  PubMed  Google Scholar 

  39. Anderson RE, Lissandrello PM, Maude MB, Matthes MT (1976) Exp Eye Res 23:149–157

    Article  CAS  PubMed  Google Scholar 

  40. Kaur K, Salomon RG, O’Neil J, Hoff H (1997) Chem Res Toxicol 10:1387–1396

    Article  CAS  PubMed  Google Scholar 

  41. Gu X, Sun M, Hazen SL, Crabb JW, Salomon RG (2003) J Org Chem 68:3749–3761

    Article  CAS  PubMed  Google Scholar 

  42. Hollyfield JG, Bonilha VL, Lu L, Rayborn ME, Yang X, Shadrach KG, Ufret RL, Salomon RG, Perez VL (2008) Nat Med 14:194–198

    Article  CAS  PubMed  Google Scholar 

  43. Peakman M, Senaldi G, Vergan D (1989) J Clin Pathol 42:1018–1025

    Article  CAS  PubMed  Google Scholar 

  44. Mombaerts P, Iacomini J, Johnson R, Herrup K, Tonegawa S, Papaioannou V (1992) Cell 68:869–877

    Article  CAS  PubMed  Google Scholar 

  45. Anderson RE (1970) Exp Eye Res 10:339–344

    Article  CAS  PubMed  Google Scholar 

  46. LaVail MM (1976) Exp Eye Res 23:277–280

    Article  CAS  PubMed  Google Scholar 

  47. Besharse JC, Hollyfield JG (1979) Invest Ophthalmol Vis Sci 18:1019–1024

    CAS  PubMed  Google Scholar 

  48. Gordon W, Rodriguez de Turco E, Bazan N (1992) Curr Eye Res 11:73–83

    Article  CAS  PubMed  Google Scholar 

  49. Rodriguez de Turco E, Parkins N, Ershov A, Bazan N (1999) J Neurosci Res 57:479–486

    Article  CAS  PubMed  Google Scholar 

  50. Sun M, Finnemann S, Febbraio M, Shan L, Annangudi S, Podrez E, Hoppe G, Darrow R, Organisciak D, Salomon R, Silverstein R, Hazen S (2006) J Biol Chem 281:4222–4230

    Article  CAS  PubMed  Google Scholar 

  51. Salomon R, Subbanagounder G, Singh U, O’Neil J, Hoff H (1997) Chem Res Toxicol 10:750–759

    Article  CAS  PubMed  Google Scholar 

  52. Brame C, Boutaud O, Davies S, Yang T, Oates J, Roden D, Roberts L 2nd (2004) J Biol Chem 279:13447–13451

    Article  CAS  PubMed  Google Scholar 

  53. Goyal J, Wang K, Liu M, Subbaiah P (1997) J Biol Chem 272:16231–16239

    Article  CAS  PubMed  Google Scholar 

  54. Ambati J, Anand A, Fernandez S, Sakurai E, Lynn B, Kuziel W, Rollins B, Ambati B (2003) Nature Med 9:1390–1397

    Article  CAS  PubMed  Google Scholar 

  55. Gottsch J, Bynoe L, Harlan J, Rencs E, Green W (1993) Arch Ophthalmol 111:126–129

    CAS  PubMed  Google Scholar 

  56. Cousins S, Espinosa-Heidmann D, Alexandridou A, Sall J, Dubovy S, Csaky K (2002) Exp Eye Res 75:543–553

    Article  CAS  PubMed  Google Scholar 

  57. Malek G, Johnson L, Mace B, Saloupis P, Schmechel D, Rickman D, Toth C, Sullivan P (2005) Proc Natl Acad Sci U S A 102:11900–11905

    Article  CAS  PubMed  Google Scholar 

  58. Fox G, Kuwabara T, Wiggert B, Redmond T, Hess H, Chader G, Gery I (1987) Clin Immunol Immunopathol 43:256–264

    Article  CAS  PubMed  Google Scholar 

  59. Hirose S, Wiggert B, Redmond M, Kuwabara T, Nussenblatt R, Chader G, Gery I (1987) Exp Eye Res 45:695–702

    Article  CAS  PubMed  Google Scholar 

  60. de Kozak Y, Verwaerde C (2002) Int Rev Immunol 21:231–253

    Article  PubMed  Google Scholar 

  61. Caspi R, Chan C, Leake W, Higuchi M, Wiggert B, Chader G (1990) J Autoimmun 3:237–246

    Article  CAS  PubMed  Google Scholar 

  62. Caspi R (2003) Immunol Res 27:149–160

    Article  CAS  PubMed  Google Scholar 

  63. Nussenblatt R (2002) Int Rev Immunol 21:273–289

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Supported by the State of Ohio BRTT Program, Columbus, Ohio; a Research Center Grant from the Foundation Fighting Blindness, Owings Mills, Maryland; a Challenge Grant from Research to Prevent Blindness, New York, NY; and by grants from the National Institutes of Health, Bethesda, Maryland, [EY014240 (JGH), EY015638 (JGH), EY014912 (VLP), and GM21249 (RGS)]. We thank Xiaoping (Annie) Yang, Mary E. Rayborn, Karen G. Shadrach, Vera L. Bonilha, and Yong Li for their help with the microscopy and immunology performed in these studies. We also thank Lisa Kuttner-Kondo, John W. Crabb, Bela Anand-Apte, and Neal S. Peachey for discussions and valuable comments during the course of these studies.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joe G. Hollyfield.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hollyfield, J.G., Perez, V.L. & Salomon, R.G. A Hapten Generated from an Oxidation Fragment of Docosahexaenoic Acid Is Sufficient to Initiate Age-Related Macular Degeneration. Mol Neurobiol 41, 290–298 (2010). https://doi.org/10.1007/s12035-010-8110-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12035-010-8110-z

Keyword

  • Inflammation
  • Retina
  • Oxidative damage
  • Age-related macular degeneration
  • Fatty acid